Exact Mass: 563.2917

Exact Mass Matches: 563.2917

Found 47 metabolites which its exact mass value is equals to given mass value 563.2917, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Fosinopril

(2S,4S)-4-cyclohexyl-1-[2-[[(1S)-2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphoryl]-1-oxoethyl]-2-pyrrolidinecarboxylic acid

C30H46NO7P (563.3012)


Fosinopril is a phosphinic acid-containing ester prodrug that belongs to the angiotensin-converting enzyme (ACE) inhibitor class of medications. It is rapidly hydrolyzed to fosinoprilat, its principle active metabolite. Fosinoprilat inhibits ACE, the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). Fosinopril may be used to treat mild to moderate hypertension, as an adjunct in the treatment of congestive heart failure, and to slow the rate of progression of renal disease in hypertensive individuals with diabetes mellitus and microalbuminuria or overt nephropathy. C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 3324

   

Fosenopril

4-cyclohexyl-1-(2-{[2-methyl-1-(propanoyloxy)propoxy](4-phenylbutyl)phosphoryl}acetyl)pyrrolidine-2-carboxylic acid

C30H46NO7P (563.3012)


   

Ser Leu Pro Tyr Ala

Ser Leu Pro Tyr Ala

C27H41N5O8 (563.2955)


   

fosinopril

(2S,4S)-4-cyclohexyl-1-[2-[[(1S)-2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphoryl]-1-oxoethyl]-2-pyrrolidinecarboxylic acid

C30H46NO7P (563.3012)


C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents CONFIDENCE standard compound; INTERNAL_ID 2247

   

Cys Lys Lys Trp

(2S)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]hexanamido]-3-(1H-indol-3-yl)propanoic acid

C26H41N7O5S (563.289)


   

Cys Lys Trp Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-3-(1H-indol-3-yl)propanamido]hexanoic acid

C26H41N7O5S (563.289)


   

Cys Trp Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]hexanamido]hexanoic acid

C26H41N7O5S (563.289)


   

Lys Cys Lys Trp

(2S)-2-[(2S)-6-amino-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]hexanamido]-3-(1H-indol-3-yl)propanoic acid

C26H41N7O5S (563.289)


   

Lys Cys Trp Lys

(2S)-6-amino-2-[(2S)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]hexanoic acid

C26H41N7O5S (563.289)


   

Lys Lys Cys Trp

(2S)-2-[(2R)-2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C26H41N7O5S (563.289)


   

Lys Lys Trp Cys

(2R)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanoic acid

C26H41N7O5S (563.289)


   

Lys Trp Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]hexanoic acid

C26H41N7O5S (563.289)


   

Lys Trp Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-indol-3-yl)propanamido]hexanamido]-3-sulfanylpropanoic acid

C26H41N7O5S (563.289)


   

Trp Cys Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2R)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]hexanamido]hexanoic acid

C26H41N7O5S (563.289)


   

Trp Lys Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]hexanamido]-3-sulfanylpropanamido]hexanoic acid

C26H41N7O5S (563.289)


   

Trp Lys Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]hexanamido]hexanamido]-3-sulfanylpropanoic acid

C26H41N7O5S (563.289)


   

GFLLD

Gly-Phe-Leu-Leu-Asp

C27H41N5O8 (563.2955)


   

LLDGF

Leu-Leu-Asp-Gly-Phe

C27H41N5O8 (563.2955)


   

SPTFL

Ser Pro Thr Phe Leu

C27H41N5O8 (563.2955)


   

LGFEV

Leu Gly Phe Glu Val

C27H41N5O8 (563.2955)


   
   

(1S)-N1-cyclopentyl-N2-(4-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-9-methylspiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]-1,2-dicarboxamide

(1S)-N1-cyclopentyl-N2-(4-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-9-methylspiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]-1,2-dicarboxamide

C31H38FN5O4 (563.2908)


   

(1R)-N1-cyclopentyl-N2-(4-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-9-methylspiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]-1,2-dicarboxamide

(1R)-N1-cyclopentyl-N2-(4-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-9-methylspiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]-1,2-dicarboxamide

C31H38FN5O4 (563.2908)


   
   
   
   
   
   
   

2-amino-3-[[3-butanoyloxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[3-butanoyloxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C26H46NO10P (563.2859)


   

2-amino-3-[[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-propanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-propanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C26H46NO10P (563.2859)


   

3-[[3-acetyloxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxy-2-aminopropanoic acid

3-[[3-acetyloxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxy-2-aminopropanoic acid

C26H46NO10P (563.2859)


   
   
   
   
   
   
   
   
   
   
   
   

2,19-dihydroxy-6,12,22-trioxo-21-(sec-butyl)-23-oxa-3,7,13,20,27-pentaazatetracyclo[22.3.1.0⁷,¹¹.0¹³,¹⁸]octacosa-2,19-diene-4-carboxylic acid

2,19-dihydroxy-6,12,22-trioxo-21-(sec-butyl)-23-oxa-3,7,13,20,27-pentaazatetracyclo[22.3.1.0⁷,¹¹.0¹³,¹⁸]octacosa-2,19-diene-4-carboxylic acid

C27H41N5O8 (563.2955)


   

(1s,4s,11s,18s,21s,24s)-21-[(2s)-butan-2-yl]-2,19-dihydroxy-6,12,22-trioxo-23-oxa-3,7,13,20,27-pentaazatetracyclo[22.3.1.0⁷,¹¹.0¹³,¹⁸]octacosa-2,19-diene-4-carboxylic acid

(1s,4s,11s,18s,21s,24s)-21-[(2s)-butan-2-yl]-2,19-dihydroxy-6,12,22-trioxo-23-oxa-3,7,13,20,27-pentaazatetracyclo[22.3.1.0⁷,¹¹.0¹³,¹⁸]octacosa-2,19-diene-4-carboxylic acid

C27H41N5O8 (563.2955)


   

(2e,4z,6r,7e)-2,4,6,8-tetramethyl-9-oxo-9-[(1s,9s,10s,11s,12r)-6,9,13-trihydroxy-5,10-dimethyl-12-(2-methylpropyl)-2-oxo-14-azatetracyclo[7.5.1.0¹,¹¹.0³,⁸]pentadeca-3,5,7,13-tetraen-10-yl]nona-2,4,7-trienoic acid

(2e,4z,6r,7e)-2,4,6,8-tetramethyl-9-oxo-9-[(1s,9s,10s,11s,12r)-6,9,13-trihydroxy-5,10-dimethyl-12-(2-methylpropyl)-2-oxo-14-azatetracyclo[7.5.1.0¹,¹¹.0³,⁸]pentadeca-3,5,7,13-tetraen-10-yl]nona-2,4,7-trienoic acid

C33H41NO7 (563.2883)


   

(1s,2s,4r,7s,8r,9s,12s,19s,20r)-5,23,24,25-tetrahydroxy-9,10,14,22-tetramethyl-7-(2-methylpropyl)-27-oxa-6-azahexacyclo[18.6.1.0²,¹⁹.0⁴,⁸.0⁴,¹².0²¹,²⁶]heptacosa-5,10,13,21,23,25-hexaene-3,18-dione

(1s,2s,4r,7s,8r,9s,12s,19s,20r)-5,23,24,25-tetrahydroxy-9,10,14,22-tetramethyl-7-(2-methylpropyl)-27-oxa-6-azahexacyclo[18.6.1.0²,¹⁹.0⁴,⁸.0⁴,¹².0²¹,²⁶]heptacosa-5,10,13,21,23,25-hexaene-3,18-dione

C33H41NO7 (563.2883)